8-K: Enpro Q3 Sales Up 9.9%, Boosts 2025 Outlook with Acquisitions

Enpro Inc. reports strong Q3 2025 results, raising full-year guidance and announcing strategic acquisitions.

Summary

• Sales increased 9.9% to $286.6 million in Q3 2025 compared to the prior-year period.
• Net income rose 9.1% to $21.6 million, with GAAP diluted earnings per share at $1.01.
• Adjusted EBITDA grew 8.1% to $69.3 million, and adjusted diluted earnings per share increased 14.4% to $1.99.
• Advanced Surface Technologies (AST) sales were up 17.3%, and Sealing Technologies sales increased 5.7%.
• Announced strategic acquisitions of Overlook Industries (closed October 8, 2025) and AlpHa Measurement Solutions (expected Q4 2025) for an aggregate of approximately $280 million in cash.
• Updated full-year 2025 guidance, raising revenue growth to 7%-8% (from 5%-7%) and adjusted EBITDA to $275 million-$280 million (from $270 million-$280 million), and adjusted diluted EPS to $7.75-$8.05 (from $7.60-$8.10).
• Generated $104.9 million in free cash flow for the nine months ended September 30, 2025, up from $82.8 million in the prior-year period.
• Ended Q3 with a net leverage ratio of 1.2x, expected to approximate 2x post-acquisitions.

Sentiment

Score: 8

Explanation: The company reported strong financial performance with significant year-over-year growth in sales, net income, and adjusted EPS. The upward revision of full-year guidance and strategic acquisitions in high-growth markets demonstrate positive momentum and a clear growth strategy. While there are some minor margin pressures and soft spots in certain markets, the overall outlook is very positive.

Positives

• Strong Q3 2025 sales growth of 9.9% to $286.6 million.
• Significant growth in Advanced Surface Technologies (AST) sales, up 17.3%, driven by precision cleaning and semiconductor tools.
• Solid 5.7% sales increase in Sealing Technologies with strong profitability.
• Net income increased 9.1% to $21.6 million.
• Adjusted diluted earnings per share grew 14.4% to $1.99.
• Adjusted EBITDA increased 8.1% to $69.3 million.
• Strategic acquisitions of Overlook Industries and AlpHa Measurement Solutions expand capabilities in high-growth biopharmaceutical manufacturing and compositional analysis markets.
• Upward revision of full-year 2025 guidance for revenue growth (7%-8%) and adjusted EBITDA ($275 million-$280 million), and a higher low-end for adjusted diluted EPS ($7.75-$8.05).
• Strong free cash flow generation of $104.9 million for the nine months ended September 30, 2025, an increase from $82.8 million in the prior-year period.
• Healthy net leverage ratio of 1.2x at quarter-end, indicating financial flexibility before acquisitions.

Negatives

• Adjusted EBITDA margin slightly decreased to 24.2% from 24.6% in the prior-year period.
• Operating margin in AST was impacted by increased investments in key initiatives and unfavorable product mix.
• Continued soft commercial vehicle OEM demand partially offset overall sales strength.
• Timing of nuclear orders impacted year-over-year comparison for Sealing Technologies.
• Increased operating expenses supporting growth initiatives partially offset higher sales.

Risks

• Economic conditions in served markets, including cyclicality and potential impact of tariffs.
• Geopolitical instability, including armed conflicts in Ukraine and the Middle East, and potential conflict affecting Taiwan.
• Uncertainties regarding government tariffs, embargoes, trade protection measures, and sanctions, which could significantly increase product costs or reduce sales.
• Uncertainties in prices and availability of raw materials, exacerbated by geopolitical conflicts and tariffs.
• Challenges in achieving anticipated growth within semiconductor, life sciences, and other technology-enabled markets, including timing of CHIPS Act support and completion of the new Arizona facility.
• Impact of fluctuations in foreign currency exchange rates or unanticipated increases in interest rates.
• Potential for unanticipated delays or problems in introducing new products.
• Risks related to labor disputes.
• Impact of competitor announcements regarding new products, services, or technological innovations.
• Changes in the company's or competitors' pricing policies.
• Reliance of the Advanced Surface Technologies segment on a small number of significant customers.
• Uncertainties in identifying and completing business acquisitions consistent with strategy and successfully integrating acquired businesses.
• Uncertainties regarding payments for contingent liabilities, including those related to discontinued operations, divested businesses, environmental matters, and employee benefits.
• Acquisition-specific risks, including the ultimate outcome, benefits, and synergies of the Overlook and AlpHa acquisitions, potential delays in closing the AlpHa acquisition due to regulatory approvals, unexpected costs, and disruptions to current plans and operations.

Future Outlook

Enpro updated its full-year 2025 guidance, now expecting revenue growth of 7%-8% (up from 5%-7%), adjusted EBITDA in the range of $275 million to $280 million (up from $270 million to $280 million), and adjusted diluted earnings per share in the range of $7.75 to $8.05 per share (up from $7.60 to $8.10). This guidance reflects the anticipated partial-quarter contributions from the recently announced acquisitions of Overlook and AlpHa.

Management Comments

• "Enpro delivered another strong quarter with sales growth of almost 10% and solid profitability even as we continue growth investments in capabilities and strategic initiatives that lay the foundation for future value creation." Eric Vaillancourt, President and CEO.
• "Sales performance was highlighted by double-digit growth in AST driven by strong demand in leading-edge precision cleaning solutions and certain semiconductor tools and assemblies." Eric Vaillancourt, President and CEO.
• "We welcomed Overlook Industries to the Enpro family on October 8th, and we look forward to completing the acquisition of AlpHa Measurement Solution during the fourth quarter. These two additions to the Enpro portfolio will extend our critical capabilities in biopharmaceutical manufacturing technologies and compositional analysis markets, two areas where we see opportunities to accelerate profitable growth." Eric Vaillancourt, President and CEO.
• "Overall, we are delighted with how the organization is executing on the Enpro 3.0 strategy in its first year and confident in our ability to build on this momentum in coming periods." Eric Vaillancourt, President and CEO.

Industry Context

The strong performance in Advanced Surface Technologies, particularly in precision cleaning and semiconductor tools, aligns with the ongoing demand in the semiconductor industry, despite potential cyclicality. The strategic acquisitions in biopharmaceutical manufacturing and compositional analysis reflect a broader industry trend towards expanding into high-growth life sciences and technology-enabled markets, diversifying beyond traditional industrial sectors. The continued softness in the commercial vehicle OEM market indicates a segment facing headwinds, contrasting with the strength in aerospace and food and pharma applications.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased guidance, strategic growth initiatives, and continued dividend payments. The acquisitions are expected to accelerate profitable growth, potentially increasing long-term shareholder value.
• Employees: Integration of Overlook Industries and AlpHa Measurement Solutions will bring new employees into the Enpro family, potentially creating new opportunities but also integration challenges.
• Customers: Expanded capabilities in biopharmaceutical manufacturing and compositional analysis through acquisitions will offer a broader range of solutions, particularly in high-demand sectors.
• Creditors: The net leverage ratio is expected to increase from 1.2x to approximately 2x post-acquisitions, which is still manageable but represents a higher debt load.

Next Steps

• Complete the acquisition of AlpHa Measurement Solutions during the fourth quarter of 2025.
• Hold a conference call on November 4, 2025, at 8:30 a.m. Eastern Time to discuss Q3 2025 financial results.
• Pay a regular quarterly dividend of $0.31 per share on December 17, 2025, to shareholders of record as of December 3, 2025.
• Continue executing on the Enpro 3.0 strategy.

Key Dates

Recommendation

Enpro delivered robust third-quarter results, exceeding prior-year performance across key financial metrics like sales, net income, and adjusted EPS. The company's strategic acquisitions of Overlook Industries and AlpHa Measurement Solutions are well-aligned with its Enpro 3.0 strategy, expanding its footprint in high-growth biopharmaceutical and compositional analysis markets. The upward revision of full-year 2025 guidance for revenue and adjusted EBITDA, coupled with a higher low-end for adjusted diluted EPS, signals strong confidence from management in future performance. Despite a slight dip in adjusted EBITDA margin and some softness in the commercial vehicle OEM market, the overall trajectory is positive, supported by strong free cash flow generation and a healthy balance sheet, even with the increased leverage post-acquisitions. These factors collectively suggest a compelling investment opportunity.

Keywords

Enpro, NPO, Q3 2025 earnings, financial results, sales growth, adjusted EBITDA, adjusted EPS, Advanced Surface Technologies, Sealing Technologies, acquisitions, Overlook Industries, AlpHa Measurement Solutions, biopharmaceutical, compositional analysis, semiconductor, industrial technology, guidance, free cash flow, NYSE